Apolipoprotein C-III in patients with systemic lupus erythematosus.

Candelaria Martín-GonzálezCarmen Ferrer-MoureJuan Carlos Quevedo-AbeledoAntonia de Vera-GonzálezAlejandra González-DelgadoJulio Sánchez-MartínMiguel Á González-GayIván Ferraz-Amaro

Published in: Arthritis research & therapy (2022)

Among SLE patients, disease activity, severity, and disease damage are independently associated with higher ApoC3 serum levels.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
end stage renal disease
ankylosing spondylitis
newly diagnosed
ejection fraction
chronic kidney disease
juvenile idiopathic arthritis
oxidative stress
prognostic factors
patient reported outcomes
patient reported